{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:43:01Z","timestamp":1789612981079,"version":"build-2803163510"},"reference-count":31,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023331","name":"Leo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022606","name":"Almirall","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/14712598.2026.2703825","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:35:13Z","timestamp":1783935313000},"page":"723-730","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Successful dose reduction of dupilumab in pediatric patients with atopic dermatitis in daily practice: results from the BioDay registry"],"prefix":"10.1080","volume":"26","author":[{"given":"Florence","family":"Vroman","sequence":"first","affiliation":[{"name":"University Medical Center Utrecht, University of Utrecht","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavian I.","family":"Baco\u015f-Cosma","sequence":"additional","affiliation":[{"name":"University Medical Center Groningen, University of Groningen","place":["Groningen, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"de Krosse","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht, University of Utrecht","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas P.A.","family":"Zuithoff","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Kamsteeg","sequence":"additional","affiliation":[{"name":"Radboud University Medical Center","place":["Nijmegen, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Moon","family":"van Tuyll van Serooskerken","sequence":"additional","affiliation":[{"name":"HagaZiekenhuis and Juliana Pediatric Hospital","place":["Den Haag, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula P.M.","family":"van L\u00fcmig","sequence":"additional","affiliation":[{"name":"Maastricht University Medical Centre+","place":["Maastricht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter R.H.","family":"Touwslager","sequence":"additional","affiliation":[{"name":"Catharina Hospital","place":["Eindhoven, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Oosting","sequence":"additional","affiliation":[{"name":"Spaarne Gasthuis","place":["Hoofddorp, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge M.","family":"Haeck","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht, University of Utrecht","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein S.","family":"de Bruin-Weller","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht, University of Utrecht","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise A.","family":"Schuttelaar","sequence":"additional","affiliation":[{"name":"University Medical Center Groningen, University of Groningen","place":["Groningen, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"de Graaf","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht, University of Utrecht","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0001-z"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.10.009"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad449"},{"key":"#cr-split#-e_1_3_7_5_1.1","unstructured":"Dupixent (dupilumab): an overview of dupixent and why it is authorised in the EU. European Medicines Agency. [updated 2025 Jan 6"},{"key":"#cr-split#-e_1_3_7_5_1.2","unstructured":"cited 2025 Jul 3]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/overview\/dupixent-epar-medicine-overview_en.pdf"},{"key":"#cr-split#-e_1_3_7_6_1.1","unstructured":"Dupixent-H-C-4390-II-0060: EPAR - Assessment report - variation. [First published 2023 Mar 23"},{"key":"#cr-split#-e_1_3_7_6_1.2","unstructured":"cited 2025 Jul 3]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/variation-report\/dupixent-h-c-4390-ii-0060-epar-assessment-report-variation_en.pdf"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-024-00859-y"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.06.054"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00683-2"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00685-0"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.2517"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18450"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.3717"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.04.026"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.70025"},{"issue":"7","key":"e_1_3_7_16_1","first-page":"750","article-title":"Economic evaluation of dupilumab for moderate-to-severe atopic dermatitis: a cost-utility analysis","volume":"17","author":"Zimmermann M","year":"2018","unstructured":"Zimmermann M, Rind D, Chapman R, et al. Economic evaluation of dupilumab for moderate-to-severe atopic dermatitis: a cost-utility analysis. J Drugs Dermatol. 2018;17(7):750\u2013756.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2254567"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15439"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad159"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18908"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15933"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17030"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad011"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.387"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2235041"},{"key":"e_1_3_7_26_1","unstructured":"Dupixent - Summary of product characteristics. Sanofi Winthrop Industrie; 2022."},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119513469"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19094"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.24.084"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2024.0146"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2026.2703825","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14712598.2026.2703825","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2026.2703825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:18:47Z","timestamp":1786699127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2026.2703825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/14712598.2026.2703825"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2026.2703825","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}